I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
INSURE: A pooled analysis of ixazomib-lenalidomide-dexameth..:
Xavier Leleu
;
Hans C. Lee
;
Jeffrey A. Zonder
...
doi:10.25402/fon.24972678.v1. , 2024
Link:
https://doi.org/10.25402/fon.24972678.v1
RT Journal T1
INSURE: A pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice - supplementary material
UL https://suche.suub.uni-bremen.de/peid=base-ftdeakinunifig:oai:figshare.com:article_24972678&Exemplar=1&LAN=DE A1 Xavier Leleu A1 Hans C. Lee A1 Jeffrey A. Zonder A1 Margaret Macro A1 Karthik Ramasamy A1 Cyrille Hulin A1 Jiri Silar A1 Matyas Kuhn A1 Kaili Ren A1 Nawal Bent-Ennakhil A1 Dasha Cherepanov A1 Dawn Marie Stull A1 Evangelos Terpos YR 2024 K1 Oncology and carcinogenesis not elsewhere classified K1 effectiveness K1 ixazomib K1 ixazomib-lenalidomide-dexamethasone K1 IRd K1 multiple myeloma K1 pooled analysis K1 progression-free survival K1 proteasome inhibitor K1 relapsed/refractory K1 routine clinical practice K1 time-to-next treatment JF doi:10.25402/fon.24972678.v1 LK http://dx.doi.org/https://doi.org/10.25402/fon.24972678.v1 DO https://doi.org/10.25402/fon.24972678.v1 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)